Marketing New Drugs Flashcards

1
Q

What is the primary goal of drug marketing?

A

To promote the safe and effective use of new drugs.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

True or False: The FDA is responsible for approving new drugs for marketing in the United States.

A

True

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What are the main phases of clinical trials for new drugs?

A

Phases 1, 2, and 3.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Fill in the blank: The __________ is the entity that submits a New Drug Application (NDA) to the FDA.

A

sponsor

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What does NDA stand for?

A

New Drug Application

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Which phase of clinical trials primarily assesses the drug’s safety?

A

Phase 1

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

True or False: Post-marketing surveillance is unnecessary after a drug is approved.

A

False

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What is a key regulatory requirement before marketing a new drug?

A

Obtaining FDA approval.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What does the term ‘indications’ refer to in drug marketing?

A

The specific conditions or diseases for which a drug is approved.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What is the purpose of Phase 3 clinical trials?

A

To confirm efficacy and monitor adverse reactions in a larger population.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Multiple Choice: Which of the following is NOT a phase of clinical trials? A) Phase 4 B) Phase 5 C) Phase 3

A

B) Phase 5

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What is the role of Institutional Review Boards (IRBs) in drug research?

A

To review and approve research protocols to ensure the safety and rights of participants.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Fill in the blank: The process of marketing new drugs begins with __________.

A

preclinical research

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What is the primary focus of Phase 2 clinical trials?

A

To evaluate the drug’s efficacy and side effects.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

True or False: The cost of bringing a new drug to market is typically low.

A

False

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What is one major factor contributing to the high cost of drug development?

A

The lengthy and complex clinical trial process.

17
Q

What does ‘orphan drug’ mean?

A

A drug developed for rare diseases affecting a small number of patients.

18
Q

Multiple Choice: Which entity typically conducts the preclinical testing of new drugs? A) FDA B) Pharmaceutical companies C) Hospitals

A

B) Pharmaceutical companies

19
Q

What is the purpose of Phase 4 clinical trials?

A

To gather additional information about a drug’s risks, benefits, and optimal use after it has been marketed.

20
Q

Fill in the blank: The __________ is a document that provides evidence of a drug’s effectiveness and safety to the FDA.

A

New Drug Application (NDA)

21
Q

What is the significance of the ‘Black Box Warning’?

A

It highlights serious risks associated with a drug.

22
Q

True or False: Drug advertisements must comply with FDA regulations.

23
Q

What does ‘informed consent’ mean in the context of clinical trials?

A

Participants must be fully informed about the study and voluntarily agree to participate.

24
Q

What is the main reason for conducting post-marketing studies?

A

To monitor long-term effects and effectiveness in a general population.

25
What is the term for the financial support provided to researchers for drug development?
Funding
26
Fill in the blank: __________ is a key consideration in the drug approval process that assesses the potential benefits against risks.
Risk-benefit analysis